SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001028348-15-000012
Filing Date
2015-09-24
Accepted
2015-09-24 14:15:00
Documents
1
Group Members
BROOKSIDE CAPITAL TRADING FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 BROOKSIDE 13G REGENXBIO AS OF 9/24/2015 RegenxbioSchedule13G.txt SC 13G 11095
  Complete submission text file 0001028348-15-000012.txt   12904
Mailing Address JOHN HANCOCK TOWER 200 CLARENDON STREET BOSTON MA 02116
Business Address JOHN HANCOCK TOWER 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
BROOKSIDE CAPITAL PARTNERS FUND LP (Filed by) CIK: 0001028348 (see all company filings)

IRS No.: 043313066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Subject) CIK: 0001590877 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89108 | Film No.: 151122851
SIC: 2836 Biological Products, (No Diagnostic Substances)